Belviq Cancer Suits Warrant Consolidation, Plaintiffs Say

Suits against Eisai Inc. and Arena Pharmaceuticals Inc. alleging the withdrawn diet drug Belviq causes cancer should be combined and sent to the Eastern District of Louisiana, seven plaintiffs told the U.S. Judicial Panel on Multidistrict Litigation

The plaintiffs, whose suits are pending in seven different federal courts, say the complex medical, scientific, and legal concepts at issue make a multidistrict proceeding especially important.

Belviq and Belviq XR are brand-name medications intended to reduce appetite by increasing feelings of fullness.

Personal injury plaintiffs allege the drugs caused various types of cancer, and say the companies failed to warn of the ...